SpeeDx to Feature PlexPCR(TM) and ResistancePlus(TM) Tests on M. genitalium at ECCMID
April 08, 2016 13:17 ET
|
SpeeDx Pty, Ltd.
SYDNEY, AUSTRALIA--(Marketwired - Apr 8, 2016) - SpeeDx Pty, Ltd. today announced that it will feature its PlexPCR™ for detection of infectious disease pathogens and the unique...
SpeeDx Announces Distribution Agreement for PlexPCR(TM) and ResistancePlus(TM) Molecular Diagnostics Products With Goffin Molecular Technologies
April 04, 2016 09:00 ET
|
SpeeDx Pty, Ltd.
SYDNEY, AUSTRALIA--(Marketwired - Apr 4, 2016) - SpeeDx Pty, Ltd. today announced a distribution agreement with Goffin Molecular Technologies B.V., a molecular diagnostic company based in the...
Retrotope Advances RT001 in Clinical Trials to Treat Friedreich's ataxia
February 22, 2016 09:00 ET
|
Retrotope
LOS ALTOS, CA--(Marketwired - Feb 22, 2016) - Retrotope, a privately held clinical stage pharmaceutical company, today announced the successful completion of the first dose cohort and the opening...
e-Vision Accelerates Development Program for First Fully Tunable Electronic Contact Lens
November 12, 2015 14:05 ET
|
e-Vision
LAS VEGAS, NV--(Marketwired - Nov 12, 2015) - E-Vision Smart Optics, Inc., a Sarasota-based company specializing in electrically-modulated tunable lens technology, announced today that it is...
Transcend Medical Announces 12-Month European Study Results of the CyPass Micro-Stent(R) at AAO 2012
November 13, 2012 13:00 ET
|
Transcend Medical
CHICAGO, IL--(Marketwire - Nov 13, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced the 12-month results of the...
Transcend Medical Launches the Transcend Vold Gonio Lens (TVG) for Improved Visualization During Micro-Invasive Glaucoma Surgery
November 12, 2012 09:00 ET
|
Transcend Medical
CHICAGO, IL--(Marketwire - Nov 12, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, today announced the commercial...
Transcend Medical Announces Four Scientific Abstracts at the American Society of Cataract and Refractive Surgery Annual Meeting
April 21, 2012 09:00 ET
|
Transcend Medical
CHICAGO, IL--(Marketwire - Apr 21, 2012) - Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced that the CyPass...
Sunshine Heart Announces Results of Its C-Pulse(R) Feasibility Trial at the Transcatheter Cardiovascular Therapeutics Conference
November 07, 2011 08:00 ET
|
Sunshine Heart, Inc.
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN--(Marketwire - Nov 7, 2011) - Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate to severe heart...
Sunshine Heart's Feasibility Trial Outcomes to Be Presented at Transcatheter Cardiovascular Therapeutics Conference
October 19, 2011 05:00 ET
|
Sunshine Heart, Inc.
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN--(Marketwire - Oct 19, 2011) - Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate heart failure,...
Sunshine Heart Appoints New US Board Member
August 03, 2011 15:19 ET
|
Sunshine Heart, Inc.
SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN--(Marketwire - Aug 3, 2011) - Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate heart failure,...